Strategic EP, LLC 13D and 13G filings for Alaunos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-16 4:58 pm Sale | 2025-10-14 | 13G | Alaunos Therapeutics, Inc. TCRT | Strategic EP, LLC | 0 0.000% | -149,827 (Position Closed) | Filing |
| 2025-09-04 06:34 am Purchase | 2025-08-21 | 13G | Alaunos Therapeutics, Inc. TCRT | Strategic EP, LLC | 149,827 6.800% | 149,827 (New Position) | Filing |